| P2093 | author name string | Regis J O'Keefe | |
| | Edward M Schwarz | |
| | J Edward Puzas | |
| | Randy N Rosier | |
| | J Jeffrey Goater | |
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro | Q28374594 |
| | Immunological defects in mice with a targeted disruption in Bcl-3 | Q28506495 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 |
| | Primary total hip arthroplasty with a cementless porous-coated anatomic total hip prosthesis: 10- to 12-year results of prospective and consecutive series | Q39225366 |
| | Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis | Q40862558 |
| | Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures | Q41444921 |
| | Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption | Q41551181 |
| | Effects of interleukin-1 on bone turnover in normal mice | Q43625701 |
| | Charnley total hip arthroplasty in patients less than fifty years old. A twenty to twenty-five-year follow-up note. | Q44108884 |
| | Gene therapy for rheumatic diseases | Q45855770 |
| | Gene therapy -- promises, problems and prospects | Q45883584 |
| | Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells | Q47270034 |
| | NF-kappa B regulates VCAM-1 expression on fibroblast-like synoviocytes | Q64380752 |
| | Bone formation and bone resorption in failed total joint arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique | Q71175942 |
| | Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis | Q71618460 |
| | Prosthetic metals interfere with the functions of human osteoblast cells in vitro | Q73422144 |
| | Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis | Q73472299 |
| | Outcome of Charnley total hip replacement across a single health region in England: the results at five years from a regional hip register | Q78175828 |
| P433 | issue | 2 | |
| P921 | main subject | gene therapy | Q213901 |
| | osteolysis | Q2035084 |
| P304 | page(s) | 169-173 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Orthopaedic Research | Q6295700 |
| P1476 | title | Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis | |
| P478 | volume | 20 | |